Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium gluconate is the sodium salt of gluconic acid, typically produced through the fermentation of glucose (PubChem CID 23672301). In clinical settings, it is not a therapeutic target such as a receptor or enzyme, but rather a component of intravenous replacement fluids used to manage electrolyte imbalances and metabolic acidosis (DailyMed, Plasma-Lyte 148). Upon administration, it undergoes metabolic oxidation to generate bicarbonate, which serves as a systemic alkalizer (NIH, LiverTox). Additionally, sodium gluconate is a highly effective chelating agent, capable of sequestering metal ions like calcium and iron in various environments (ScienceDirect). Its primary role in medicine is to support physiological homeostasis rather than to modulate a specific signaling pathway.
Acts as an electrolyte replenisher and a metabolic precursor to bicarbonate; it is oxidized in the body to provide an alkalizing effect and helps maintain osmotic pressure.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium gluconate.